Molecular Partners AG (SWX:MOLN)
Switzerland · Delayed Price · Currency is CHF 3.390
+0.050 (1.50%)
Oct 2, 2026, 12:11 PM CET
Molecular Partners AG Stock Forecast
Stock Price Forecast
According to 2 analysts polled by S&P Global, Molecular Partners AG stock has a consensus rating of "Buy" and an average price target of CHF 9.00. The average 1-year stock price forecast is 165.49% higher than the current stock price, while the lowest is CHF 3.00 (-11.50%) and the highest is CHF 15.00 (+342.48%).
Price Target: CHF 9.00 (+165.49%)
Analyst Consensus: Buy
Price Target
ChartAnalyst Ratings
The average analyst rating for Molecular Partners AG stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.
Recommendation Trends
| Rating | Jan '26 | Feb '26 | Mar '26 | May '26 | Jul '26 | Aug '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 1 | 1 | 1 | 1 |
| Buy | 0 | 0 | 0 | 0 | 0 | 0 |
| Hold | 1 | 1 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 2 | 2 | 2 | 2 | 2 | 2 |
Financial Forecast
Revenue This Year
5.58M
Revenue Next Year
30.69M
from 5.58M
Increased by 450.00%
EPS This Year
-0.65
from -1.65
EPS Next Year
0.23
from -0.65
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is CHF.